FEATURED NEWS

• Nicolette A. Louissaint To Join HDA as Senior Vice President, Policy and Strategic Planning

  December 10, 2021

  The Healthcare Distribution Alliance (HDA) is pleased to announce that Nicolette A. Louissaint, PhD, MBA, has been named the organization’s Senior Vice President of Policy and Strategic Planning. In this newly created role, Louissaint will become a member of HDA’s Executive Management Team and report to President and Chief Executive Officer Chester “Chip” Davis, Jr. She will join HDA on January 18, 2022, from her current role serving as Executive Director and President of Healthcare Ready in Washington, D.C.

• Distribution Industry Remained Efficient and Resilient During First Year of COVID-19

  December 9, 2021

  Data released by the Healthcare Distribution Alliance (HDA) Research Foundation indicate that despite the challenges of COVID-19, pharmaceutical distributors maintained efficiencies to deliver millions of vaccines and medicines to providers — and ultimately patients. Published today, the 92nd Edition HDA Factbook: The Facts, Figures & Trends in Healthcare provides benchmarks and trends for the U.S. pharmaceutical supply chain.

• Sean Spears of Eisai Honored With 2021 Nexus Award for Lifetime Achievement

  November 17, 2021

  The HDA Research Foundation recognized Sean Spears of Eisai, Inc., with the 2021 Nexus Award for Lifetime Achievement last night at the Thirteenth Annual CEO Roundtable Fundraiser in Washington, D.C. The award is the healthcare distribution industry’s highest honor recognizing career accomplishments.

• HDA Statement on FDA Commissioner Nominee Dr. Robert Califf

  November 12, 2021

  Healthcare Distribution Alliance (HDA) President and CEO Chester “Chip” Davis, Jr., released the following statement regarding President Biden’s nomination of Dr. Robert Califf as FDA Commissioner.

• HDA Foundation Survey Reveals Uneven Progress on Rx Product Serialization, with 2023 DSCSA Requirements Around the Corner

  November 1, 2021

  The pharmaceutical supply chain’s progress on implementing product serialization requirements to comply with the Drug Supply Chain Security Act (DSCSA) has slowed as the November 2023 deadline for compliance comes into view.